RankingsPricing
  1. US-listed companies
  2. Bionik Laboratories Corp.

Bionik Laboratories Corp.BNKL

Market cap
$12.48
P/E ratio
Back to summarized table
Income statementBalance sheetCash flow
Dec 31,
2011		Dec 31,
2014		Dec 31,
2015		Mar 31,
2017		Mar 31,
2018		Mar 31,
2019		Mar 31,
2020		Mar 31,
2021		Mar 31,
2022		Mar 31,
2023
Cash and cash equivalents12,455-7543,650507,311446,7792120
Accounts receivable---383,903212,7302846,964451,905274,844453,084
Prepaid expenses and other current assets--188,217228,047433,6551221862,603
Inventories---228,249237,443405,6821692,16311
Total current assets12,4553,24271146353
Equipment--87,103227,421159,961192,528154,14493,57791,234187,673
Other assets---------8,694
Operating Lease, Right-of-Use Asset---------254,650
Tradenames and Trademarks---------34,000
Goodwill---222222114-99,552
Total assets12,4553,242729293119953
Accounts payable--134,718784,726724,6731857,093454,809305,095557,610
Accrued liabilities332-57,8401222760,026873,0301
Operating leases, current---------22,067
Deferred Revenue, Current------616,063268,083313,854342,354
Total current liabilities6,33242,580-6835412
Operating leases, non-current---------234,448
Deferred revenue, net of current portion-------303,917256,646303,292
Convertible notes---------2
Total liabilities6,33242,5806----625
Preferred Stock, Value, Issued----------
Common Stock, Value, Issued4,989-72,42896,794249,5993,8585,1265,7026,8796,989
Additional paid-in capital13,661-71,3771139567485889899
Accumulated deficit---10,647,888-15,588,554-35,776,340-46,357,373-71,373,870-84,994,327-95-100
Accumulated other comprehensive income--42,14942,14942,14942,14942,14942,14928,09629,815
Total stockholders' (deficit) equity6,123-39,338977,9882320271333-1,640,588
Total liabilities and stockholders' equity12,4553,242729293119953